作者: Keren Shichrur , Isaac Yaniv , Smadar Avigad
DOI:
关键词: Health care provider 、 DISEASE RELAPSE 、 Relapse risk 、 Standard treatment 、 Internal medicine 、 Lymphoblastic Leukemia 、 Oncology 、 Medicine
摘要: Described herein are methods for determining the prognosis of a patient diagnosed with Acute Lymphoblastic Leukemia (ALL), and particularly risk disease relapse following standard treatment. Also described systems treatment that directed by health care provider, which include prognostic treatments recommended patients determined to have specific risk.